These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15133786)

  • 1. Factors influencing the spontaneous reporting of adverse drug reactions--the experience of the Slovak Republic.
    Tisonová J; Szalayová A; Kriska M; Gibala P; Foltán V
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):333-7. PubMed ID: 15133786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angioedema induced by ACE inhibitors and angiotensin II-receptor antagonists: analysis of 98 cases].
    Schuster C; Reinhart WH; Hartmann K; Kuhn M
    Schweiz Med Wochenschr; 1999 Mar; 129(9):362-9. PubMed ID: 10198947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy.
    Motola D; Vargiu A; Leone R; Conforti A; Moretti U; Vaccheri A; Velo G; Montanaro N
    Drug Saf; 2008; 31(7):609-16. PubMed ID: 18558794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased reporting of adverse reactions to ACE inhibitors associated with limitations to drug reimbursement for angiotensin-II receptor antagonists.
    Cosentino M; Leoni O; Michielotto D; Punginelli M; Lecchini S; Frigo G
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):509-12. PubMed ID: 11699617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reporting of adverse drug reactions in Iceland in 1999 to 2004].
    Jóhannsson M; Agústsdóttir E
    Laeknabladid; 2006 Apr; 92(4):283-7. PubMed ID: 16582456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.
    Alharbi FF; Kholod AAV; Souverein PC; Meyboom RH; de Groot MCH; de Boer A; Klungel OH
    Fundam Clin Pharmacol; 2017 Dec; 31(6):676-684. PubMed ID: 28767167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Comput Biol Med; 2006; 36(7-8):748-67. PubMed ID: 16185681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an adverse drug reaction reporting system at a teaching hospital.
    Baniasadi S; Fahimi F; Shalviri G
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.